Milestone Pharmaceuticals Inc.

NasdaqGS:MIST Stok Raporu

Piyasa değeri: US$95.3m

Milestone Pharmaceuticals Yönetim

Yönetim kriter kontrolleri 3/4

Milestone Pharmaceuticals CEO'su Joe Oliveto, Mar2017 tarihinde atandı, in görev süresi 7.67 yıldır. in toplam yıllık tazminatı $ 1.98M olup, şirket hissesi ve opsiyonları dahil olmak üzere 30.4% maaş ve 69.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.43% ine doğrudan sahiptir ve bu hisseler $ 410.65K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.6 yıl ve 5.6 yıldır.

Anahtar bilgiler

Joe Oliveto

İcra Kurulu Başkanı

US$2.0m

Toplam tazminat

CEO maaş yüzdesi30.4%
CEO görev süresi7.7yrs
CEO sahipliği0.4%
Yönetim ortalama görev süresi4.6yrs
Yönetim Kurulu ortalama görev süresi5.6yrs

Son yönetim güncellemeleri

Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Jun 07
Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Recent updates

Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Jun 07
Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?

Sep 13
Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?

We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

Mar 07
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

Oct 15
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

Jun 24
We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely

Feb 25
We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely

We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow

Aug 25
We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow

Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth

Apr 02
Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth

What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition

Jan 15
What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition

First patient enrolled in Milestone Pharmaceuticals' late-stage study of etripamil in PSVT

Nov 18

Milestone Pharmaceuticals EPS beats by $0.09

Nov 13

CEO Tazminat Analizi

Joe Oliveto'un ücretlendirmesi Milestone Pharmaceuticals'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$48m

Mar 31 2024n/an/a

-US$55m

Dec 31 2023US$2mUS$602k

-US$60m

Sep 30 2023n/an/a

-US$59m

Jun 30 2023n/an/a

-US$59m

Mar 31 2023n/an/a

-US$59m

Dec 31 2022US$3mUS$584k

-US$58m

Sep 30 2022n/an/a

-US$62m

Jun 30 2022n/an/a

-US$62m

Mar 31 2022n/an/a

-US$44m

Dec 31 2021US$4mUS$509k

-US$43m

Sep 30 2021n/an/a

-US$35m

Jun 30 2021n/an/a

-US$32m

Mar 31 2021n/an/a

-US$46m

Dec 31 2020US$4mUS$470k

-US$50m

Sep 30 2020n/an/a

-US$60m

Jun 30 2020n/an/a

-US$60m

Mar 31 2020n/an/a

-US$61m

Dec 31 2019US$785kUS$458k

-US$55m

Sep 30 2019n/an/a

-US$47m

Jun 30 2019n/an/a

-US$40m

Mar 31 2019n/an/a

-US$29m

Dec 31 2018US$1mUS$360k

-US$23m

Dec 31 2017US$851kUS$364k

-US$8m

Tazminat ve Piyasa: Joe 'nin toplam tazminatı ($USD 1.98M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 655.65K ).

Tazminat ve Kazançlar: Joe 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Joe Oliveto (56 yo)

7.7yrs

Görev süresi

US$1,978,092

Tazminat

Mr. Joseph G. Oliveto, also known as Joe, M.B.A. has been Chief Executive Officer and President of Milestone Pharmaceuticals Inc. March 2017 and has been its Director since July 2017. Mr. Oliveto served as...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Joseph Oliveto
CEO, President & Director7.7yrsUS$1.98m0.43%
$ 410.7k
Amit Hasija
CFO & Executive VP of Corporate Development5.2yrsUS$1.01m0.029%
$ 27.7k
David Bharucha
Chief Medical Officer2.8yrsUS$1.22m0.023%
$ 21.8k
Philippe Douville
Founderno dataVeri yokVeri yok
Jeffrey Nelson
Chief Operating Officer4.4yrsVeri yokVeri yok
Kim Fox
Vice President of Communications1.2yrsVeri yokVeri yok
Philip Sager
Chief Medical Advisor & Member of the Scientific Advisory Board4.8yrsVeri yokVeri yok
Guy Rousseau
SVP of Regulatory Affairs and Quality Managementno dataVeri yokVeri yok
Lorenz Muller
Chief Commercial Officer7.1yrsUS$645.72k0.20%
$ 192.1k
Anita Holz
VP & Head of Medical Affairs2.3yrsVeri yokVeri yok

4.6yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: MIST 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.6 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Joseph Oliveto
CEO, President & Director7.3yrsUS$1.98m0.43%
$ 410.7k
Philippe Douville
Founder4.8yrsVeri yokVeri yok
Philip Sager
Chief Medical Advisor & Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Harry Leighton
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Daniel Omstead
Observer7.3yrsVeri yokVeri yok
Harry Kopelman
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Peter Kowey
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
John DiMarco
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Paul Dorian
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Michael Tomsicek
Independent Non-Executive Director5.6yrsUS$153.27k0.023%
$ 21.6k
John Camm
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Robert Wills
Independent Chairman of the Board4.1yrsUS$176.77k0.023%
$ 21.6k

5.6yrs

Ortalama Görev Süresi

68yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: MIST 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.6 yıldır).